2020年11月,中国医药生物技术协会公布了新增的13个通过备案的干细胞临床研究项目,其中之一与肝脏疾病相关,是四川省人民医院承担的《脐带间充质干细胞移植治疗乙肝后终末期肝硬化的单中心、前瞻性临床研究》。
截止目前,国内已经有近10个与肝脏疾病相关的干细胞临床研究项目通过备案。
我国是肝病大国,对新疗法有着庞大的需求,随着干细胞临床研究取得进展,未来更多的难治性肝病患者将得到更有效的治疗。
参考资料:
[1] https://www.closerlookatstemcells.org/stem-cells-medicine/liver-disease
[2] Tao YC, Wang ML, Chen EQ, Tang H. Stem cells transplantation in the treatment of patients with liver failure. Curr Stem Cell Res Ther. 2018;13:193–201.
[3] Progress in mesenchymal stem cell–based therapy for acute liver failure
https://stemcellres.biomedcentral.com/articles/10.1186/s13287-018-0972-4
[4] 脐血间充质干细胞移植治疗肝硬化的研究进展
http://www.cnki.com.cn/Article/CJFDTotal-XXHB201306015.htm
[5] ParekkadanB,vanPollD,SuganumaK,CarterEA, BerthiaumeF,TillesAW ,Yarm ushM L.M esenchymalstem cell -derived molecules reverse fulminant hepatic failure.PLoSOne2007;2:e941
[6] Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases https://pubmed.ncbi.nlm.nih.gov/28620221/
[7]Zhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., Geng, H., Jin, L., Lau, G.K.K. and Wang, F.‐S. (2012), Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology, 27: 112-120. doi:10.1111/j.1440-1746.2011.07024.x
[8] Lin BL, Chen JF, Qiu WH, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial. Hepatology. 2017;66(1):209-219.